Shree Ganesh Remedies

820.00
+2.10
(0.26%)
Market Cap (₹ Cr.)
₹1,050
52 Week High
950.05
Book Value
₹
52 Week Low
461.05
PE Ratio
37.35
PB Ratio
8.60
PE for Sector
38.75
PB for Sector
4.65
ROE
24.79 %
ROCE
25.46 %
Dividend Yield
0.06 %
EPS
₹21.90
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
89.85 %
Net Income Growth
168.45 %
Cash Flow Change
563.40 %
ROE
-7.12 %
ROCE
-41.57 %
EBITDA Margin (Avg.)
43.90 %

Financial Results

Quarterly Financials
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
11
17
10
12
14
16
14
17
22
22
18
22
23
30
27
34
29
39
25
Expenses
9
12
7
7
10
10
10
13
15
16
13
16
17
21
20
24
20
20
17
EBITDA
2
5
3
5
4
5
4
5
7
6
5
6
7
9
7
10
9
18
9
Operating Profit %
10 %
24 %
19 %
36 %
24 %
33 %
24 %
26 %
27 %
23 %
24 %
25 %
24 %
29 %
25 %
28 %
30 %
45 %
33 %
Depreciation
0
1
1
1
0
1
1
1
1
1
1
1
1
1
1
1
2
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
-0
0
0
0
0
0
0
0
Profit Before Tax
1
4
2
4
3
4
3
4
6
5
4
5
6
8
6
9
7
16
6
Tax
0
2
0
1
0
1
1
1
1
1
1
1
1
1
2
2
2
4
2
Net Profit
1
3
2
3
3
3
2
3
4
4
3
4
4
7
5
7
4
13
5
EPS in ₹
1.05
2.71
1.65
3.09
2.77
3.03
2.34
2.51
3.50
3.14
2.39
3.28
3.56
5.53
3.86
5.32
3.52
10.01
3.62

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
15
16
21
36
41
52
61
77
138
171
Fixed Assets
5
4
4
6
14
16
19
27
58
81
Current Assets
10
11
17
28
26
35
38
45
62
70
Capital Work in Progress
0
0
0
0
0
0
2
3
15
17
Investments
0
0
0
4
4
7
3
0
0
5
Other Assets
11
11
17
25
23
29
37
47
64
69
Total Liabilities
2
2
5
7
8
10
11
15
51
49
Current Liabilities
2
2
4
7
7
10
10
15
20
19
Non Current Liabilities
0
0
0
0
1
0
0
0
31
30
Total Equity
13
14
16
29
34
42
50
62
87
122
Reserve & Surplus
12
13
15
20
25
33
40
50
75
109
Share Capital
1
1
1
9
9
9
10
12
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
-0
2
4
-5
1
2
0
5
7
Investing Activities
1
1
0
-3
-0
-3
-1
-12
-51
-33
Operating Activities
-1
-2
2
-1
-5
4
3
13
17
30
Financing Activities
-0
-0
-0
8
-0
-0
-1
-1
39
10

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Feb 2023
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
68.39 %
68.39 %
69.12 %
69.12 %
69.12 %
69.12 %
69.12 %
68.27 %
68.27 %
69.32 %
69.33 %
69.33 %
69.33 %
69.33 %
69.33 %
69.33 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.02 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
31.61 %
31.61 %
30.88 %
30.88 %
30.86 %
30.86 %
30.88 %
31.73 %
31.73 %
30.68 %
30.67 %
30.67 %
30.67 %
30.67 %
30.67 %
30.66 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20
370.65 43,587.78 27.93 15,621.20 35.25 1,298 478.78 51.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
44.17
ATR(14)
Less Volatile
38.50
STOCH(9,6)
Oversold
12.67
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-8.34
ADX(14)
Weak Trend
16.87
UO(9)
Bearish
35.86
ROC(12)
Downtrend But Slowing Down
-6.27
WillR(14)
Oversold
-86.16